X-120873904-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001145718.3(CT47B1):c.892G>A(p.Gly298Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,075,815 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 56 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001145718.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000627 AC: 5AN: 79758Hom.: 0 Cov.: 12 AF XY: 0.0000669 AC XY: 1AN XY: 14942
GnomAD3 exomes AF: 0.000193 AC: 33AN: 170710Hom.: 0 AF XY: 0.000305 AC XY: 19AN XY: 62352
GnomAD4 exome AF: 0.0000874 AC: 94AN: 1075815Hom.: 0 Cov.: 31 AF XY: 0.000160 AC XY: 56AN XY: 351007
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000627 AC: 5AN: 79758Hom.: 0 Cov.: 12 AF XY: 0.0000669 AC XY: 1AN XY: 14942
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.892G>A (p.G298R) alteration is located in exon 2 (coding exon 2) of the CT47B1 gene. This alteration results from a G to A substitution at nucleotide position 892, causing the glycine (G) at amino acid position 298 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
CT47B1: BP4, BS2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at